MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze ALC →
    • FindStock Picks / Stock Screener
    • Value · ALCIntrinsic Value Calculator
    • Invest · ALCInvestment Case
    • Hold · ALC5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
ALC stock logo

ALC

Alcon Inc.

$66.18
-0.4
 (-0.6%)
Exchange:  NYSE
Market Cap:  31.991B
Shares Outstanding:  488.7M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – SpecialtiesView industry performance
   
CEO:  David J. Endicott
Full Time Employees:  25000
Address: 
Chemin de Blandonnet 8
Geneva
GE
1214
CH
Website:  https://www.alcon.com
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Click to read more…

Revenue Segmentation

MarketSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
ALALC logoALCAlcon Inc.32.0B49.319.23.2%
STSTE logoSTESTERIS plc21.7B26.121.88.7%
QDQDEL logoQDELQuidelOrtho Corporation885.3M—16.8-16.1%
MLMLAB logoMLABMesa Laboratories, Inc.685.4M14813.53.1%
MAMASS logoMASS908 Devices Inc.465.4M——-18.7%
BWBWAY logoBWAYBrainsWay Ltd.448.7M47.636.97.7%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/06 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue9,455,0009,911,00010,401,000
Gross Profit5,247,0005,512,0005,745,000
EBITDA2,242,0002,676,0002,495,000
Operating Income1,039,0001,413,0001,360,000
Net Income974,0001,018,000980,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets29,614,00030,347,00031,555,000
Total Liabilities8,990,0008,794,0009,520,000
Total Stockholders Equity20,624,00021,553,00022,034,000
Total Debt5,135,0005,136,0005,246,000
Cash and Cash Equivalents1,094,0001,676,0001,527,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow1,388,0002,077,0002,271,000
Capital Expenditure-851,000-670,000-543,000
Free Cash Flow537,0001,407,0001,728,000
Net Income1,039,613.1501,018,000980,000
Net Change in Cash114,000582,000-149,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)13,619,704.823Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)14,153,098.749Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)13,887,486.497Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)4,650,369.980Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)4,817,221.606Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)4,734,135.028Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)2,787,686.339Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)2,930,457.965Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)2,859,362.429Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)4,690,296.747Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)4,873,984.707Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)4,782,514.276Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)5.760Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)5.910Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)5.620Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)9Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)13Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
9.611B  ?P/S
 (TTM)
: 
2.89
?Net Income
 (TTM)
: 
987.14M  ?P/E
 (TTM)
: 
49.32
?Enterprise Value
 (TTM)
: 
35.21B  ?EV/FCF
 (TTM)
: 
20.92
?Dividend Yield
 (TTM)
: 
0.56%  ?Payout Ratio
 (TTM)
: 
26.38%
?ROE
 (TTM)
: 
2.91%  ?ROIC
 (TTM)
: 
3.24%
?Net Debt
 (TTM)
: 
3.303B  ?Debt/Equity
 (TTM)
: 
0.25
?P/B
 (TTM)
: 
1.44  ?Current Ratio
 (TTM)
: 
2.09

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
19.24Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates ALC intrinsic value between $82.85 – $84.69 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate ALC Intrinsic Value

Common questions about ALC valuation

Is Alcon Inc. (ALC) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Alcon Inc. (ALC) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is ALC a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether ALC trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is ALC’s P/E ratio?

You can see ALC’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for ALC?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is ALC a good long-term investment?

Whether ALC fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Alcon Inc.

  • Alcon Inc. intrinsic value calculatorEstimate what the business is worth
  • Alcon Inc. 5-year outlookWhat has to go right, and what could go wrong
ALC

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.6
MarketSnap

Trading Metrics:

Open: 66.95   Previous Close: 66.58
Day Low: 66.04   Day High: 67.02
Year Low: 61.84   Year High: 87.64
Price Avg 50: 68.54   Price Avg 200: 72.55
Volume: 1.454M   Average Volume: 1.867M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
16-10-2026 15:57
FDA Approves Alcon's BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
Algoma Central (TSE:ALC) Shares Cross Above 50 Day Moving Average – Here’s Why
07-10-2026 03:01
Algoma Central (TSE:ALC) Shares Cross Above 50 Day Moving Average – Here’s Why
Alcon Prices EUR 500 Million Senior Notes Offering
26-08-2026 17:00
Alcon Prices EUR 500 Million Senior Notes Offering
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy
17-08-2026 06:10
Alcon: A Strong Company Trading Close To Its Intrinsic Value, Buy
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs
11-08-2026 10:21
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
10-08-2026 16:30
New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze ALC →
    • FindStock Picks / Stock Screener
    • Value · ALCIntrinsic Value Calculator
    • Invest · ALCInvestment Case
    • Hold · ALC5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Settings
    • Public profile ↗
  • Log in

Media

Watch Listen Read